- Excellent financial health (Piotroski 7/9)
- High gross margin of 81.6%
- Strong return on equity of 735.0%
Xeris Pharmaceuticals Inc stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session
(Updated on Jun 03, 2026)
The Xeris Pharmaceuticals Inc stock price fell by -1.83% on the last day (Wednesday, 3rd Jun 2026) from $6.00 to $5.89. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 3.10% from a day low at $5.81 to a day high of $5.99. The price has fallen in 6 of the last 10 days and is down by -0.51% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -199 thousand shares and in total, 1 million shares were bought and sold for approximately $6.75 million.
The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.87 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 12.27% during the next 3 months and, with a 90% probability hold a price between $6.59 and $7.68 at the end of this 3-month period.
XERS Signals & Forecast
There are few to no technical positive signals at the moment. The Xeris Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $6.13 and $6.19. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 07, 2026, and so far it has fallen -11.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Xeris Pharmaceuticals Inc stock
Xeris Pharmaceuticals Inc finds support from accumulated volume at $5.61 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.180 between high and low, or 3.10%. For the last week, the stock has had daily average volatility of 3.71%.
Our recommended stop-loss: $5.61 (-4.75%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 18 days ago.)
Trading Expectations (XERS) For The Upcoming Trading Day Of Thursday 4th
For the upcoming trading day on Thursday, 4th we expect Xeris Pharmaceuticals Inc to open at $5.90, and during the day (based on 14 day Average True Range), to move between $5.76 and $6.02, which gives a possible trading interval of +/-$0.253 (+/-4.40%) up or down from last closing price. If Xeris Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 4.40% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $6.04 (2.55%) than the support at $5.61 (4.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Xeris Pharmaceuticals Inc stock A Buy?
Xeris Pharmaceuticals Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.
Current score:
-0.952
Hold/Accumulate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 4, 2026 - $5.90 ( 0.113%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
XERS Performance
Trading levels for XERS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.08 | 3.17% |
| R2 | 6.01 | 2.00% |
| R1 | 5.97 | 1.28% |
| Price | 5.89 | |
| S1 | 5.83 | -1.05% |
| S2 | 5.79 | -1.78% |
| S3 | 5.72 | -2.94% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.63 | 12.56% |
| R2 | 6.07 | 3.06% |
| R1 | 6.04 | 2.55% |
| Price | 5.89 | |
| S1 | 5.61 | -4.75% |
| S2 | 5.60 | -4.92% |
| S3 | 5.30 | -10.02% |
FAQ
Click here for our free guide on how to buy Xeris Pharmaceuticals Inc Stock.
Buy XERS